News - Page 185 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Lobe Sciences Enters into Joint Venture with Virtual Psychedelics Incorporated to Develop Multi-Sensory Pods for Clinical Psychedelic Use

Lobe Sciences Enters into Joint Venture with Virtual Psychedelics Incorporated to Develop Multi-Sensory Pods for Clinical Psychedelic Use

Post published:April 27, 2021
Post category:Press Release

Read more about the article Red Light Holland and Halo Collective Create Red Light Oregon, Inc. – Forwarding Intentions to Enter Oregon Medicinal Psychedelic Market

Red Light Holland and Halo Collective Create Red Light Oregon, Inc. – Forwarding Intentions to Enter Oregon Medicinal Psychedelic Market

Post published:April 27, 2021
Post category:Press Release

Read more about the article Revive Therapeutics Files for FDA Orphan Drug Designation for Psilocybin in Traumatic Brain Injury

Revive Therapeutics Files for FDA Orphan Drug Designation for Psilocybin in Traumatic Brain Injury

Post published:April 27, 2021
Post category:Press Release

Read more about the article Bright Minds Biosciences Appoints Industry Experts for Key Roles and Expands Scientific Advisory Team

Bright Minds Biosciences Appoints Industry Experts for Key Roles and Expands Scientific Advisory Team

Post published:April 27, 2021
Post category:Press Release

Read more about the article Awakn Life Sciences Initiates New Chemical Entity Development Program with Evotec as Research Partner and Addiction Expert, Prof. David Nutt, as Program Lead

Awakn Life Sciences Initiates New Chemical Entity Development Program with Evotec as Research Partner and Addiction Expert, Prof. David Nutt, as Program Lead

Post published:April 27, 2021
Post category:Press Release

Read more about the article MINDCURE Announces Partnership with SOMA Breath Inc. to License its Breathwork Program and Develop Custom Breathwork for Psychedelic-Assisted Psychotherapies within iSTRYM

MINDCURE Announces Partnership with SOMA Breath Inc. to License its Breathwork Program and Develop Custom Breathwork for Psychedelic-Assisted Psychotherapies within iSTRYM

Post published:April 27, 2021
Post category:Press Release

Read more about the article MindMed Begins Trading on Nasdaq

MindMed Begins Trading on Nasdaq

Post published:April 27, 2021
Post category:Press Release

Read more about the article Psyched Wellness Initiates the Next Pre-Clinical Trial Study on AME-1

Psyched Wellness Initiates the Next Pre-Clinical Trial Study on AME-1

Post published:April 27, 2021
Post category:Press Release

Read more about the article PharmaTher Expands Patent Portfolio with Filing of U.S. Patent Application for Ketamine and Repurposing of Psychedelics with panaceAI™

PharmaTher Expands Patent Portfolio with Filing of U.S. Patent Application for Ketamine and Repurposing of Psychedelics with panaceAI™

Post published:April 27, 2021
Post category:Press Release

Read more about the article MindMed Becomes Second Psychedelic Drug Development Company to List on the Nasdaq

MindMed Becomes Second Psychedelic Drug Development Company to List on the Nasdaq

Post published:April 27, 2021
Post category:News

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.